Progyny, Inc. - Common Stock (PGNY)
30.10
+1.04 (3.58%)
NASDAQ · Last Trade: Nov 5th, 1:44 AM EST
News & Press Releases
Progyny Q3 Earnings Call Highlightsmarketbeat.com
Progyny (NASDAQ:PGNY) raised the midpoint of its full-year 2026 guidance after reporting record third-quarter revenue and profitability and securing a record 1.3 million new covered lives during its latest selling season.
The fertility and family-building benefits company expects the majority of th
Via MarketBeat · November 5, 2026
Progyny (NASDAQ:PGNY) Stock Jumps on Q3 Earnings Beat and Record Selling Season Outlookchartmill.com
Via Chartmill · November 4, 2026
Progyny (NASDAQ:PGNY) reports Q3 2026 in line with expectations
Fertility benefits company Progyny (NASDAQ:PGNY) met Wall Street’s revenue expectations in Q3 2026, with revenue up 8.9% year on year to $341.3 million. The ...
Via StockStory · November 4, 2026
Progyny, Inc. Announces Third Quarter 2026 Results
Reports Record Third Quarter Results for Revenue, Gross Profit, Adjusted EBITDA and Net IncomeSelling Season Yields Record 1.3 Million New Covered Lives with Another Year of Near 100% Retention Raises Midpoint of Full Year Guidance Ranges
By Progyny, Inc. · Via GlobeNewswire · November 4, 2026
Progyny earnings: what to look for from PGNY
Fertility benefits company Progyny (NASDAQ:PGNY) will be reporting results this Wednesday after the bell. Here’s what to expect. Progyny beat analysts’ reven...
Via StockStory · November 2, 2026
Progyny Inc (NASDAQ:PGNY): Strong Growth With a Bull Flag Technical Setupchartmill.com
Via Chartmill · October 30, 2026
Progyny (NASDAQ:PGNY): A Quality Investing Watchlist Candidatechartmill.com
Via Chartmill · September 21, 2026
Progyny (NASDAQ:PGNY): An Affordable Growth Stock With Strong Earnings and Reasonable Valuationchartmill.com
Via Chartmill · August 25, 2026
New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits
Research presented at ASRM 2026 Scientific Congress & Expo highlights the importance of early engagement and personalized support in helping patients navigate fertility care
By Progyny, Inc. · Via GlobeNewswire · October 28, 2026
1 cash-producing stock for long-term investors and 2 we find risky
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via StockStory · October 28, 2026
3 Reasons to sell PGNY and 1 stock to buy instead
What a fantastic six months it’s been for Progyny. Shares of the company have skyrocketed 51.1%, hitting $27.77. This performance may have investors wonderin...
Via StockStory · October 28, 2026
Progyny (NASDAQ:PGNY): A Decent Value Stock Combining Reasonable Valuation and Solid Fundamentalschartmill.com
Via Chartmill · August 20, 2026
New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model
More than 70% of members in the study reported symptom improvement, with the greatest gains among those receiving both personalized coaching and menopause-trained provider care
By Progyny, Inc. · Via GlobeNewswire · October 26, 2026
Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report
NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended September 30, 2026, after the close of the market on Wednesday, November 4, 2026.
By Progyny, Inc. · Via GlobeNewswire · October 21, 2026
Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after investors rotated into defensive assets and priced in rising expectations that midter...
Via StockStory · October 19, 2026
3 Value Stocks Walking a Fine Line
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...
Via StockStory · October 19, 2026
Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting
NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, announced today that it will present new research evaluating real-world outcomes from its Menopause and Midlife program and exhibit at The Menopause Society 2026 Annual Meeting in San Diego, October 20 – 24, 2026.
By Progyny, Inc. · Via GlobeNewswire · October 15, 2026
Why Are Progyny (PGNY) Shares Soaring Today
What Happened? Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 6% in the afternoon session after the company announced that its annual sell...
Via StockStory · October 7, 2026
Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics
Expecting 1.2 Million New Covered Lives from Commitments to Date and Anticipated Remaining Decisions
By Progyny, Inc. · Via GlobeNewswire · October 7, 2026
3 Profitable Stocks with Warning Signs
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Via StockStory · September 24, 2026
Spotting Winners: Progyny (NASDAQ:PGNY) And Health Insurance Providers Stocks In Q2
Let’s dig into the relative performance of Progyny (NASDAQ:PGNY) and its peers as we unravel the now-completed Q2 health insurance providers earnings season....
Via StockStory · September 9, 2026
1 Russell 2000 Stock to Consider Right Now and 2 That Underwhelm
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...
Via StockStory · August 28, 2026
3 Healthcare Stocks We Steer Clear Of
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
Via StockStory · August 27, 2026
3 of Wall Street’s Favorite Stocks We Keep Off Our Radar
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Via StockStory · August 25, 2026
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlookmarketbeat.com
Progyny (NASDAQ:PGNY) CEO Pete Anevski said the company expects member engagement and utilization to rebound following a more pronounced summer seasonal slowdown, while early renewal and new-client commitments have increased management’s confidence in its outlook for the remainder of the year.
Spea
Via MarketBeat · August 16, 2026